NCT07106463View on ClinicalTrials.gov

Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications

Active, not recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

August 29, 2026

Study Completion Date

August 29, 2026

Conditions

IBD (Inflammatory Bowel Disease)Colon Cancer

Trial Locations (1)

98124

"Azienda Ospedaliera Universitaria G.Martino", Messina

All Listed Sponsors

lead

University of Messina

OTHER

NCT07106463 - Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications | Biotech Hunter | Biotech Hunter